About Panome Bio
Panome Bio is a company based in St. Louis (United States) founded in 2022.. Panome Bio has raised $6 million across 1 funding round from investors including Telegraph Hill Partners and BioGenerator Ventures. Panome Bio offers products and services including Next-Generation Metabolomics, Panome Proteomics, Integrated Multi-omics, Targeted Metabolomics, and Global Phosphoproteomics. Panome Bio operates in a competitive market with competitors including Zifo RnD Solutions, Ephicacy, Conexus, Syne Qua Non and Exploristics, among others.
- Headquarter St. Louis, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6 M (USD)
in 1 rounds
-
Latest Funding Round
$6 M (USD), Series A
Feb 15, 2023
-
Investors
Telegraph Hill Partners
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Panome Bio
Panome Bio offers a comprehensive portfolio of products and services, including Next-Generation Metabolomics, Panome Proteomics, Integrated Multi-omics, Targeted Metabolomics, and Global Phosphoproteomics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides untargeted metabolomics for biomarker discovery and research.
Enables comprehensive proteome profiling for scientific experiments.
Integrates metabolomics and proteomics data for mechanistic insights.
Offers precise quantitative analysis of specific metabolites.
Maps phosphorylation events in unbiased proteome coverage.
Unlock access to complete
Unlock access to complete
Funding Insights of Panome Bio
Panome Bio has successfully raised a total of $6M through 1 strategic funding round. The most recent funding activity was a Series A round of $6 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $6.0M
-
First Round
First Round
(15 Feb 2023)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2023 | Amount | Series A - Panome Bio | Valuation | Telegraph Hill Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Panome Bio
Panome Bio has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Telegraph Hill Partners and BioGenerator Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science, medical device and healthcare companies
|
Founded Year | Domain | Location | |
|
Venture capital and acceleration are provided to life science startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Panome Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Panome Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Panome Bio Comparisons
Competitors of Panome Bio
Panome Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zifo RnD Solutions, Ephicacy, Conexus, Syne Qua Non and Exploristics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Clinical data management services are provided to biopharma sector.
|
|
| domain | founded_year | HQ Location |
Biostatistics and statistical programming services are provided for clinical development.
|
|
| domain | founded_year | HQ Location |
Natural gas transmission and storage services are provided in Latvia.
|
|
| domain | founded_year | HQ Location |
Major European functional service provider offering services for data management, EDC, and biostatistics
|
|
| domain | founded_year | HQ Location |
Data analysis and management services are provided to clients.
|
|
| domain | founded_year | HQ Location |
Provider of diversified outsourcing services for pharmaceutical, biotech, and medical device companies
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Panome Bio
Frequently Asked Questions about Panome Bio
When was Panome Bio founded?
Panome Bio was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Where is Panome Bio located?
Panome Bio is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Is Panome Bio a funded company?
Panome Bio is a funded company, having raised a total of $6M across 1 funding round to date. The company's 1st funding round was a Series A of $6M, raised on Feb 15, 2023.
What does Panome Bio do?
Panome Bio was established in 2022 in St. Louis, United States, within the healthcare technology sector. Clinical data analytics services are delivered to support research and decision-making processes. Operations center on processing and interpreting clinical datasets for various applications. The company maintains its presence through the domain panomebio.com, serving clients in the United States and potentially beyond. Focus remains on factual data handling without additional sectors noted.
Who are the top competitors of Panome Bio?
Panome Bio's top competitors include Zifo RnD Solutions, Exploristics and Conexus.
What products or services does Panome Bio offer?
Panome Bio offers Next-Generation Metabolomics, Panome Proteomics, Integrated Multi-omics, Targeted Metabolomics, and Global Phosphoproteomics.
Who are Panome Bio's investors?
Panome Bio has 2 investors. Key investors include Telegraph Hill Partners, and BioGenerator Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.